NEOS Investment Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$107M Buy
269,580
+25,047
+10% +$10.9M 0.4% 44
2026
Q1
$113M Buy
244,533
+46,916
+24% +$23.7M 0.57% 32
2025
Q4
$112M Buy
197,617
+45,179
+30% +$24.1M 0.65% 24
2025
Q3
$68.2M Buy
152,438
+57,444
+60% +$27.6M 0.51% 31
2025
Q2
$51.6M Buy
94,994
+33,539
+55% +$17.5M 0.64% 24
2025
Q1
$30.4M Buy
61,455
+16,476
+37% +$9.11M 0.58% 31
2024
Q4
$23.5M Buy
44,979
+8,832
+24% +$4.6M 0.55% 30
2024
Q3
$17.8M Buy
36,147
+6,501
+22% +$3.03M 0.54% 33
2024
Q2
$13.2M Buy
29,646
+9,197
+45% +$3.66M 0.54% 32
2024
Q1
$8.16M Buy
20,449
+3,831
+23% +$1.45M 0.51% 37
2023
Q4
$5.61M Buy
16,618
+843
+5% +$251K 0.53% 36
2023
Q3
$4.61M Buy
+15,775
New +$4.93M 0.59% 33

Other funds holding ISRG

NEOS Investment Management's ISRG Position: Q2 2026 in Review

NEOS Investment Management increased its Intuitive Surgical (ISRG) stake by 10% in Q2 2026, buying an estimated $10.9M and bringing the position to 269,580 shares worth $107M. The position accounts for 0.4% of the portfolio, ranked #44.

NEOS Investment Management first reported a position in ISRG in Q3 2023 and has held it in 12 quarters since. The position peaked at $113M in Q1 2026. 2,254 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • NEOS Investment Management held 269,580 shares of Intuitive Surgical worth $107M as of Q2 2026.
  • NEOS Investment Management bought 25,047 Intuitive Surgical shares in Q2 2026, an estimated $10.9M.
  • Intuitive Surgical made up 0.4% of NEOS Investment Management's portfolio in Q2 2026, its #44 holding.
  • NEOS Investment Management first reported a position in Intuitive Surgical in Q3 2023 and has held it in 12 quarters since.
  • NEOS Investment Management's Intuitive Surgical position peaked at $113M in Q1 2026.
  • 2,254 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.